Codexis Inc (CDXS) support and resistance · rev $59.3M
Codexis Inc (CDXS) is a biotechnology company listed on US.
This page maps Codexis Inc (CDXS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CDXS revenue for 2024-12-31 was $59.3M. Net income was -$65.3M. Revenue was down 15.4% from 2023-12-31 to 2024-12-31. CDXS currently screens at market cap $257.6M.
CDXS currently screens at market cap $257.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CDXS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CDXS quote page for the session range and the stock page for the full model.
Not investment advice.